Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250570 · ClinicalTrials.gov registry record · NA
Distress Tolerance for Benzodiazepine Discontinuation
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05250570 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 1 participants.
The verdict
NCT05250570, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy (OAT) who currently use benzodiazepines versus a Relaxation Therapy (RT) control condition. The DT-BD intervention is an adjunctive psychosocial intervention in people seeking to discontinue (BZD) use.
Interventions
- BEHAVIORAL Relaxation Therapy
- BEHAVIORAL Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2022-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05250570
The ClinicalTrials.gov registry entry for NCT05250570 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Relaxation Therapy is the first listed.
NCT05250570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05250570 about?
NCT05250570 is a clinical study titled "Distress Tolerance for Benzodiazepine Discontinuation". The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy (OAT) who currently use benzodiazepines versus a Relaxation Therapy (RT) control condition. The DT-BD intervention is an adju...
What is the current status of trial NCT05250570?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-06-17. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT05250570?
The interventions under investigation include: Relaxation Therapy (BEHAVIORAL), Distress Tolerance - Benzodiazepine Discontinuation (DT-BD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05250570?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.